Nat. Rev. Rheumatol. doi: /nrrheum

Slides:



Advertisements
Similar presentations
Figure 3 Life expectancy at birth in all countries included
Advertisements

Figure 1 Lymphocytes during the disease
Figure 1 Role of innate lymphoid cells (ILCs) in steady state,
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Connexins in cartilage
Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Figure 1 Grip strength across the lifecourse
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Factors underlying metabolic alterations in osteoarthritis
Figure 1 Induction of immune tolerance
Figure 4 Ex vivo synovial tissue culture viability
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 5 Defects in the JAK–STAT signalling pathway
Figure 2 Main functions of IL-1
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Targeted versus untargeted metabolomics approaches
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Simplified EULAR and GRAPPA
Figure 2 Simplified EULAR and GRAPPA
Figure 4 Antinuclear antibodies and disease activity in SLE
Figure 3 Transcriptome studies performed in the target
Figure 1 Biosimilar development process
Figure 2 Shared genetic loci in systemic autoimmune diseases
Figure 7 Defects in apoptosis
Figure 3 Defects in the T cell receptor signalling pathway
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Strategies to achieve therapeutic inhibition of IL-1
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Post-test probability as a function of pre-test
Figure 2 Overlap of associated loci among five rheumatic diseases
Figure 2 Interaction effects between heterozygous HLA‑DRB1
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Statistical approaches for the analysis of metabolomic data
Figure 3 Cell-surface markers for NP cell differentiation
Figure 6 Lack of IRF5 causes a reduction in neutrophil influx
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Multi-hit model for autoimmune diseases
Figure 1 Simplified EULAR and GRAPPA
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Emerging hallmarks of T cells in rheumatoid arthritis
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Role of TGFβ in a normal and an osteoarthritic joint
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 6 Combining population-wide and high-risk strategies
Figure 1 Treat to target, remission and low disease activity in SLE
Figure 1 Biospecimen handling pipeline
Figure 1 The current model of the pathogenesis of SLE
Figure 6 Metabolism of pterins
Figure 1 Reproductive health in patients with rheumatic diseases
Figure 1 Principles for the diagnosis and management of osteoarthritis
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Chronic inflammation and DNA damage in people with SLE
Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality
Figure 1 Overall worldwide prevalence ranges for SLE
Figure 2 Phenotypes of osteoarthritis
Figure 1 Patterns of joint and organ involvement in rheumatic disease
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 The main effects of adipokines on bone remodelling in osteoarthritis Figure 2 | The main effects of adipokines on bone remodelling in osteoarthritis.
Nat. Rev. Rheumatol. doi: /nrrheum
Presentation transcript:

Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.220 Figure 4 Types of integrative approaches for unsupervised clustering analysis Figure 4 | Types of integrative approaches for unsupervised clustering analysis. Integrative clustering approaches can be divided into four types, depending on whether a concatenation method or non-concatenation method is used, and whether the approach is based on statistical modelling (model-based) or on the transformation of data into a common feature space (transformation-based). Concatenation or non-concatenation approaches differ in the point in which the layers of information are combined (at an early stage of the process or at the very end stage, respectively). Transformation or model-based methods are statistically methods that are defined based on how the key clustering information is captured from the different datasets. The model-based methods model the data mathematically, whereas the transformation-based methods reduce the information down to features that summarize the original information. Barturen, G. et al. (2018) Moving towards a molecular taxonomy of autoimmune rheumatic diseases Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.220